Overview

Interaction of BI 691751 With Itraconazole

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Investigation of the relative bioavailability of a single dose of BI 691751 when given alone and together with itraconazole; safety and tolerability
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Hydroxyitraconazole
Itraconazole